Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Windtree Therapeutics Engages New Growth Advisors for Potential Strategic Transaction

Dec 04, 2024•over 1 year ago

Contract Type

partnership

PennsylvaniaBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Windtree Therapeutics has engaged New Growth Advisors as its strategic advisor to explore opportunities regarding its cardiovascular portfolio, including a potential out-licensing transaction or asset sale. The company seeks to leverage positive results for istaroxime in addressing diverse opportunities and securing potentially non-dilutive funding via a partnership.

Company Information

Company

Windtree Therapeutics

Location

Pennsylvania, United States

About

Windtree Therapeutics, Inc. is a pharmaceutical company focused on developing novel therapeutics for the treatment of a broad range of diseases. The company is publicly listed on NasdaqCM under the ticker symbol WINT and has a strong emphasis on advancing and commercializing innovative product candidates.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Windtree Therapeutics's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.